Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

28/02/14	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
03/02/14	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
31/01/14	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/11/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
31/10/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)
16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	31/12/2020
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.66%	-0.46%	+15.37%	+76.92%	48.41B
OTSUKA HOLDINGS CO., LTD.	+2.20%	+1.18%	+62.94%	+112.48%	34.99B
CIPLA LIMITED	+1.26%	-1.32%	-4.27%	+34.48%	11.62B
ZYDUS LIFESCIENCES LIMITED	-0.46%	-3.92%	+15.26%	+80.81%	11.47B
KRKA, D. D.	-1.12%	-0.19%	+36.83%	+136.73%	8.99B
ONO PHARMACEUTICAL CO., LTD.	+1.52%	+3.77%	+49.89%	-4.79%	6.88B
GEDEON RICHTER	-0.17%	-3.65%	+13.46%	+31.78%	6.62B
GLENMARK PHARMACEUTICALS LIMITED	-0.59%	-4.15%	+2.49%	+191.04%	6.43B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-7.92%	-22.19%	-35.23%	-0.12%	5.75B
Average	-0.66%	-2.72%	+17.42%	+73.26%	15.69B
Weighted average by Cap.	+0.03%	-1.39%	+25.85%	+82.32%

Employees

Sector